TherapeuticsMD, Inc.

TXMD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 11, 2026 QUARTERLY REPORT
8-K Aug 11, 2026 CURRENT REPORT
SCHEDULE 13G/A Aug 5, 2026
10-Q May 12, 2026 QUARTERLY REPORT
8-K May 12, 2026 CURRENT REPORT
SCHEDULE 13G Apr 6, 2026
10-K/A Apr 1, 2026 ANNUAL REPORT
NT 10-K Apr 1, 2026 NOTIFICATION OF LATE FILING
8-K Mar 30, 2026 CURRENT REPORT
10-K Mar 30, 2026 ANNUAL REPORT
8-K Jan 21, 2026 CURRENT REPORT
4 Dec 29, 2025
8-K Dec 16, 2025 CURRENT REPORT
8-K Nov 13, 2025 CURRENT REPORT
10-Q Nov 12, 2025 QUARTERLY REPORT
4 Nov 5, 2025
4 Nov 5, 2025
4 Nov 5, 2025
4 Nov 5, 2025
ARS Nov 3, 2025 ARS
DEFA14A Nov 3, 2025 PROXY STATEMENT
DEF 14A Nov 3, 2025 PROXY STATEMENT
PRE 14A Oct 24, 2025 PROXY STATEMENT
10-Q Aug 12, 2025 QUARTERLY REPORT
8-K Aug 12, 2025 CURRENT REPORT
← Newer Page 1 of 46 · 1146 filings Older →